Newsletter – April 2021

In this newsletter edition, we invite you to provide input to the three very important surveys on the sexual and reproductive health in arthritis care, the COVID-19 vaccine access and the COVID-19 Global Rheumatology Alliance. Register and join us for the Shared decision making webinar on April 25th to be hosted by Dr. Claire Barber, Dr. Glen Hazlewood and Dr. Karine Toupin April.

Newsletter – March 2021

This month we continue informing you about the rollout of the COVID-19 vaccine which is currently underway and what this means to many people living with rheumatic diseases. Read more.

Newsletter – February 2021

This month CAPA Board members were involved in the guideline panel discussions on the new COVID-19 vaccination recommendation from the Canadian Rheumatology Association, attended and participated in the annual 2021 Canadian Arthritis Research Conference, contributed as panel moderators and presenters, and many more.

Newsletter – January 2021

Welcome to 2021! "The 2020 was a year like no other where our homes have become the focus of our lives, our workplace, a classroom, and our sanctuarys", said the CAPA President Linda Wilhelm. January 2021 had been a very busy start of the new year for CAPA team, as we have been engaged in the development of the COVID-19 vaccine decision aid, writing a letter to NACI and public health officials across Canada, providing patient input to CADTH submissions for new drugs and many more.

Newsletter – December 2020

2020 has been a challenging year for so many of us! As CAPA team, we have tried our best to support the arthritis community throughout the pandemic by addressing drug shortages, developing evidence-based resources, hosting a virtual fashion show and many more. To end the year on a lighter note, the CAPA Board of Directors wish you the best holiday season and best of luck in the year ahead!

Newsletter – November 2020

This month CAPA has introduced its #ArthritisThenNow infographic designed to describe how arthritis treatments and life has changed for people living with inflammatory arthritis over the last 20 years! Read more about many other activities and projects we have been involved into!

Newsletter – October 2020

This month CAPA has teamed up with CreakyJoints in the United States and Australia to bring our readers special content devoted to the World Arthritis Day for them to learn what it’s like to live with arthritis during the pandemic from a global perspective.

Newsletter – September 2020

In this newsletter edition, we are celebrating the September Arthritis Awareness Month and presenting our new video with Board member and fashion designer, Michael Kuluva, as he speaks with 2nd VP, Laurie Proulx and...much more in this edition. Join us in raising awareness about arthritis!

A Call for Action to #PrioritizePain #PrioriteDouleur in Canada

Canadian Pain Task Force released its final report An Action Plan for Pain in Canada. Add your voice to the call to #PrioritizePain. Read the report and learn how you can make your voices heard on the issue of pain in Canada.

Join Dr. Stephanie Garner for a Session on COVID Vaccine for All RA Patients

Dr. Stephanie Garner will be holding a Zoom session for all rheumatology patients to answer your COVID Vaccine related questions.

CAPA Shared Decision Making Webinar on April 25th

On April 25th, CAPA hosted the webinar with rheumatologists Drs. Claire Barber and Glen Hazelwood and health researcher and occupational therapist, Dr. Karine Toupin April who are leading projects that support #shareddecisionmaking​ in rheumatology. Watch this video to learn more!

Questions You May Wish to Ask Your Healthcare Provider about Biosimilars

Are you considering talking to your healthcare provider about biosimilars or has your healthcare provider talked to you already about biosimilars? We have put together some questions that might be helpful to be part of a conversation with your healthcare provider about biosimilars and brand name biologics.

Invitation to Complete the Global Rheumatology Alliance COVID-19 Vax Survey

We invite you to complete the Global Rheumatology Alliance COVID-19 Vax Survey and help researchers in learning how people with rheumatic disease make decisions regarding the vaccines in light of their rheumatic disease.

CAPA’s Feedback to VCAG Recommendations on Exceptions to Extended Dose Intervals for COVID-19 vaccines

CAPA wrote this letter due to concerns about the time delay that the National Advisory Council on Immunization (NACI) has deemed acceptable between first and second doses of vaccinations for people living with forms of inflammatory arthritis and who are on immunosuppressants.

Meet CAPA Board member – Emily Sirotich

We continue introducing our new Board members and invite you to listen to Emily Sirotich’s story. Emily is a patient partner and a current PhD student in Health Research Methodology at McMaster University. “The COVID pandemic really pushed the real impact that patients can have not only as participants in research but people who lead [&

New Arthritis+Patient App to Test

Please join us to try a new educational companion, a free, user-friendly tool Arthritis+Patient App that is designed to provide patient education and self-management. Learn more about its functionality and use here.